JP2004510683A5 - - Google Patents

Download PDF

Info

Publication number
JP2004510683A5
JP2004510683A5 JP2001501263A JP2001501263A JP2004510683A5 JP 2004510683 A5 JP2004510683 A5 JP 2004510683A5 JP 2001501263 A JP2001501263 A JP 2001501263A JP 2001501263 A JP2001501263 A JP 2001501263A JP 2004510683 A5 JP2004510683 A5 JP 2004510683A5
Authority
JP
Japan
Prior art keywords
antibody
tumor
radioimmunotherapy
clarifier
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001501263A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004510683A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/015477 external-priority patent/WO2000074729A2/en
Publication of JP2004510683A publication Critical patent/JP2004510683A/ja
Publication of JP2004510683A5 publication Critical patent/JP2004510683A5/ja
Pending legal-status Critical Current

Links

JP2001501263A 1999-06-07 2000-06-07 放射免疫療法において断片に付着されるα線エミッタまたはβ線エミッタ Pending JP2004510683A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13863599P 1999-06-07 1999-06-07
PCT/US2000/015477 WO2000074729A2 (en) 1999-06-07 2000-06-07 Alpha or beta emitters to fragments in radioimmunotherapy

Publications (2)

Publication Number Publication Date
JP2004510683A JP2004510683A (ja) 2004-04-08
JP2004510683A5 true JP2004510683A5 (https=) 2005-06-02

Family

ID=22482926

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001501263A Pending JP2004510683A (ja) 1999-06-07 2000-06-07 放射免疫療法において断片に付着されるα線エミッタまたはβ線エミッタ

Country Status (6)

Country Link
US (2) US6667024B1 (https=)
EP (1) EP1187637A2 (https=)
JP (1) JP2004510683A (https=)
AU (1) AU5727000A (https=)
CA (1) CA2374001A1 (https=)
WO (1) WO2000074729A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107090A (en) 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US6136311A (en) 1996-05-06 2000-10-24 Cornell Research Foundation, Inc. Treatment and diagnosis of cancer
US6683162B2 (en) * 2000-09-15 2004-01-27 Sloan Kettering Institute Of Cancer Research Targeted alpha particle therapy using actinium-255 conjugates
US7514078B2 (en) 2001-06-01 2009-04-07 Cornell Research Foundation, Inc. Methods of treating prostate cancer with anti-prostate specific membrane antigen antibodies
WO2002098897A2 (en) 2001-06-01 2002-12-12 Cornell Research Foundation, Inc. Modified antibodies to prostate-specific membrane antigen and uses thereof
EP1427377A4 (en) 2001-09-20 2006-04-12 Cornell Res Foundation Inc METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING SKIN DISORDERS USING SPECIFIC BINDING AGENTS FOR A PROSTATE-SPECIFIC MEMBRANE ANTIGEN
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
US7651689B2 (en) * 2002-11-15 2010-01-26 Albert Einstein College Of Medicine Of Yeshiva University Methods of applying ionization radiation for therapy of infections
WO2004062722A2 (en) * 2003-01-08 2004-07-29 Sloan Kettering Institute For Cancer Research Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers
ATE408712T1 (de) 2003-01-10 2008-10-15 Millennium Pharm Inc Verfahren zur bestimmung des wiederauftretens von prostata krebs
US7820787B2 (en) 2003-01-23 2010-10-26 The Regents Of The University Of California Multi-functional antibodies
US7528235B2 (en) 2003-01-23 2009-05-05 The Regents Of The Univarsity Of California Multi-functional antibodies
US7402385B2 (en) 2003-02-11 2008-07-22 Albert Einstein College Of Medicine Of Yeshiva University Radiolabeled antibodies for treatment of tumors
US6900507B1 (en) * 2004-01-07 2005-05-31 Micron Technology, Inc. Apparatus with silicide on conductive structures
US20050247330A1 (en) * 2004-04-30 2005-11-10 Hp Intellectual Corp. Liquid presence sensor
US7618627B2 (en) 2004-06-03 2009-11-17 The Regents Of The University Of California Method of increasing radiation sensitivity by inhibition of beta one integrin
US20060018827A1 (en) * 2004-07-08 2006-01-26 Ekaterina Dadachova Positron therapy of inflammation, infection and disease
US8463365B2 (en) * 2007-09-19 2013-06-11 Oncofluor, Inc. Method for imaging and treating organs and tissues

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4831122A (en) * 1986-01-09 1989-05-16 Regents Of The University Of Minnesota Radioimmunotoxins
CA2100709C (en) * 1992-07-27 2004-03-16 Maurits W. Geerlings Method and means for site directed therapy
US5843894A (en) * 1995-03-21 1998-12-01 Center For Molecular Medicine And Immunology Methods for reduced renal uptake of antibody fragments
US5580838A (en) * 1995-06-05 1996-12-03 Patterson; James A. Uniformly plated microsphere catalyst
ATE458499T1 (de) * 1995-06-07 2010-03-15 Immunomedics Inc Verbesserte abgabe von diagnostischen und therapeutischen stoffen an einem zielort
AU6659298A (en) * 1997-02-18 1998-09-08 Thomas Jefferson University Compositions that bind to pancreatic cancer cells and methods of using the same

Similar Documents

Publication Publication Date Title
JP2004510683A5 (https=)
CY2020003I2 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
DE60142342D1 (de) Antikörper gegen doppelintegrinen, zusammensetzungen, verfahren und verwendungen
FR13C0068I2 (fr) Conjugues du maytansinoide dm1 avec l'anticorps trastuzumab, attache par une liaison non-clivable, et son utilisation dans le traitement des tumeurs.
DE60222658D1 (de) Monoklonaler anti-cd-40-antikörper
CY2014038I1 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
EE200300568A (et) Tsütotoksilised CD44 antikeha immuunokonjugaadid
CY1109211T1 (el) Kit για ραδιοεπισημανση πρωτεϊνων με υττριο-90
CY2012003I2 (el) Αντισωματα που συνδεονται ανοσοειδικως προς blys
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DK1185299T3 (da) Anvendelse af antistoffer mod CD20 til behandling af graft versus host disease
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
GB0008305D0 (en) Treatment of fungal infections
DE3482905D1 (de) Monoklonale antikoerper gegen lungenkrebs des "nicht-kleine-zellen"-typs.
DE69530078D1 (de) Antigen/antikörper spezifitätsaustauscher
WO2000074729A3 (en) Alpha or beta emitters to fragments in radioimmunotherapy
DK1411962T3 (da) Terapi for pancreacancer med monoklonalt stof
DE60126482D1 (de) Einkettige antikörper gegen eine p53 mutante
EP1227159A4 (en) MONOCLONAL ANTIBODY, HYBRIDOMA, IMMUNITY TEST AND DIAGNOSTIC KIT
DE60141297D1 (de) Gegen das menschliche bst2 antigen gerichteter monoklonaler antikörper
EP1742654A4 (en) ANTI-LFL2 ANTIBODIES FOR THE DIAGNOSIS, FORECAST AND TREATMENT OF CANCER
TR200103432T2 (tr) Engelleyici monoklonal VLA-1 antikoru ve enflamasyonlu hastalıkların tedavisinde kullanımı.
WO2004003155A3 (en) Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
DE69115104D1 (de) Composition comprising at least two different antibodies or fragments thereof.